|
Market Closed -
London S.E.
16:35:04 23/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 4.500 GBX | 0.00% |
|
-5.26% | -59.09% |
| 07-30 | WINNERS & LOSERS: Vanquis cuts outlook; Zoo Digital loss narrows | AN |
| 07-29 | EARNINGS AND TRADING: Hargreaves Services results beat guidance | AN |
| Market Cap | 285M 381M 340M 314M 533M 36.18B 542M 3.78B 1.5B 18.96B 1.43B 1.4B 59.77B | P/E 2026 * |
-4.95x | P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 329M 440M 393M 363M 616M 41.8B 626M 4.37B 1.73B 21.9B 1.65B 1.62B 69.04B | EV / Sales 2026 * |
5.5x | EV / Sales 2027 * | - |
| Free-Float |
11.23% | Yield 2026 * |
-
| Yield 2027 * | - |
London S.E.GBX
| Markets | Quality | ||
|---|---|---|---|
London S.E.
| AGY | Delayed | |
Deutsche Boerse AG
| HHU | Delayed | |
Börse Stuttgart
| HHU | Delayed | |
Boerse Muenchen
| HHU | Real-time |
| 1 week | -5.26% | ||
| Current month | -5.26% | ||
| 1 month | -5.26% | ||
| 3 months | -18.18% | ||
| 6 months | -58.72% | ||
| Current year | -59.09% |
| 1 week | 4 | 5 | |
| 1 month | 4 | 5 | |
| Current year | 4 | 12.1 | |
| 1 year | 4 | 12.1 | |
| 3 years | 1.26 | 12.1 | |
| 5 years | 0.8 | 40.5 | |
| 10 years | 0.8 | 40.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Manuel Llobet
CEO | Chief Executive Officer | 62 | 30/06/2009 |
Shaun Furlong
DFI | Director of Finance/CFO | - | 10/08/2023 |
Matthias Kramer
PRN | Corporate Officer/Principal | - | 30/04/2013 |
| Director | Title | Age | Since |
|---|---|---|---|
Manuel Llobet
BRD | Director/Board Member | 62 | 10/06/2009 |
Peter Jensen
CHM | Chairman | 75 | 03/01/2011 |
| Director/Board Member | 69 | 05/06/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 13/06/26 | Free | Chief Financial Officer | 2,300,000 | 0.0363% | ||
| 12/03/26 | ZQ Capital Ltd.
| Others | Company | 150,925,926 | 2.4575% | |
| 12/03/26 | ZQ Capital Ltd.
| Others | Company | 1,893,776,143 | 30.8360% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| 0.00% | -5.26% | -43.04% | +240.91% | 381M | ||
| -2.54% | +1.75% | +56.75% | +117.82% | 1,165B | ||
| -1.42% | +4.16% | +36.73% | +72.42% | 645B | ||
| +0.16% | +0.79% | +24.91% | +95.34% | 504B | ||
| -0.31% | +2.95% | +39.36% | +63.56% | 380B | ||
| -1.34% | +0.06% | +65.81% | +41.49% | 363B | ||
| -0.68% | +1.67% | +22.07% | +50.94% | 297B | ||
| -1.20% | +0.99% | +2.26% | +22.95% | 269B | ||
| -1.79% | +1.20% | +48.41% | +57.55% | 237B | ||
| -0.73% | -0.85% | +28.47% | +100.57% | 195B | ||
| Average | -0.85% | +1.76% | +28.17% | +86.35% | 405.59B | |
| Weighted average by Cap. | -1.15% | +3.17% | +40.78% | +80.35% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 59.9M 80.12M 71.55M 66.1M 112M 7.61B 114M 795M 315M 3.99B 301M 294M 12.56B | - |
| Net income | -55.7M -74.51M -66.53M -61.46M -104M -7.07B -106M -740M -293M -3.71B -280M -274M -11.68B | - |
| Net Debt | 44.2M 59.12M 52.8M 48.77M 82.69M 5.61B 84.06M 587M 232M 2.94B 222M 217M 9.27B | - |
Employees
584
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 23/10/26 | GBX 4.500 | 0.00% | 4,347 |
| 22/10/26 | GBX 4.500 | 0.00% | 0 |
| 21/10/26 | GBX 4.500 | 0.00% | 2,071 |
| 20/10/26 | GBX 4.500 | 0.00% | 393,738 |
| 19/10/26 | GBX 4.500 | 0.00% | 150,249 |
Sell
Buy

Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.0450GBP
Average target price
0.1300GBP
Spread / Average Target
+188.89%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- AGY Stock
Select your edition
All financial news and data tailored to specific country editions

















